Research Technician - Department of Immunology, School of Medicine - (20001226) Description This is a limited term position lasting one year from hire with possibility of renewal for a second year. This is a grant funded position and is not eligible for severance pay. The Department of Immunology is a new Department at Tufts Medical School that is at an exciting stage of development. It is our goal to become a world-class center for the study of inflammation and immune mediated disease processes that will co-ordinate and develop research efforts in this area across the Medical School. In the coming years the department will be expanding with new faculty, whose primary focus is the role of inflammation in a range of chronic diseases. The current strength of the department lies with an integrated faculty interested in understanding how immunological, physiological, and metabolic pathways interact to produce dysregulated innate and adaptive host responses in a wide array of diseases. These include autoimmune disorders, cardiovascular diseases, arthritis, infectious diseases, cancer, and obesity. An essential translational aspect of the Department-wide research effort will be the targeted development of novel therapeutics for both treatment and prevention of immune-mediated diseases. Qualifications Basic Requirements:
An employee in this position must complete all appropriate background checks at the time of hire, promotion, or transfer. Equal Opportunity Employer - minority/females/veterans/disability/sexual orientation/gender identity. Primary Location: United States-Massachusetts-Boston Job: Research Organization: Department of Immunology Employee Status: Limited Appointment Schedule: Full-time Job Posting: Jan 4, 2021, 7:55:46 PM
|
RESEARCH TECHNICIAN, School of Medicine, Biochemistry | Boston, Massachusetts |
Boston University | 4 Days Ago |
Research Technician B | Einstein/Resnick - Bronx, New York |
Albert Einstein College of Medicine | 4 Days Ago |
Research Technician- Bandopadhayay Lab | Boston, Massachusetts |
Dana-Farber Cancer Institute | 2 Weeks Ago |